Exercise tolerance in angina is improved by mivazerol—An alpha2-adrenoceptor agonist
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
In a double-blind, placebo-controlled, randomized trial of treadmill exercise tolerance in six patients with chronic stable angina, intravenous mivazerol 1 µg, 2 µg, and 3 µg/kg increased in the time to onset of angina by 39%, 48%, and 76%; the time to 1-mm ST depression by 36%, 76%, and 104%; and total exercise duration by 15%, 23%, and 30%, respectively. In a subsequent double-blind, placebo-controlled, randomized trial involving a further 12 patients, a single oral dose of mivazerol of 800 µg, 1200 µg, and 1600 µg increased the time to onset of angina by 4%, 11%, and 30%; the time to 1-mm ST depression by 33%, 43%, and 53%; and the total exercise duration by 10%, 18%, and 23%, respectively. Mivazerol is an imidazole derivative with agonist properties at the alpha2-adrenoceptor and appears to be an effective antianginal. Mivazerol may improve exercise performance by attenuating the effects of exercise-induced sympathetic nervous system activity on the ischemic myocardium.
- Maseri A. Medical therapy of chronic stable angina pectoris.Circulation 1990;82:2258–2262.
- Kharkevitch T, Guyaux M, Gobert J, Wulfert E. Mivazerol. A new α2-receptor agonist reduces ischaemia produced by coronary occlusion in rats and dogs.Cardiovasc Drugs Ther 1991;5:S407.
- Kharkevitch T, Noyer M, Guyaux M, Riemersma RA, Gobert JK, Wulfert E. Mivazerol, a new α2-adrenergic agonist with anti-ischaemic effects in animal models of myocardial ischaemia. In:Proc Eur Assoc Cardiothorac Anaesthesiologists, 1992.
- Du XJ, Hoet B, Kharkevitch T, Riemersma RA. Mivazerol inhibits neuronal norepinephrine release during myocardial ischaemia.J Mol Cell Cardiol 1992;24:S21.
- Bruce RA. Exercise testing of patients with coronary heart disease. Principles and normal standards of evaluation.Ann Clin Res 1971;3:323–332.
- Prichard BNC, Aelling WH, Richardson GA. The action of intravenous oxprenolol, practolol, propranolol and sotalol on acute exercise tolerance in angina pectoris: The effect on heart rate and the electrocardiogram.Postgrad Med J 1970;43(Nov suppl):77–83.
- Subramanian VB, Bowles MJ, Khurmi NS, Davies AB, Raftery EB. Randomised double-blind comparison of verapamil and nifedipine in chronic stable angina.Am J Cardiol 1982;50:696–703.
- Thadani U, Fung HL, Darke AC, Parker JO. Oral isosorbide dinitrate in the treatment of angina pectoris.Circulation 1980;62:491–502.
- Cocco G, Strozzi C, Haeusler G, Chu D, Amrein R, Padovan GC. The therapeutic value of clonidine in patients with coronary heart disease.Eur J Cardiol 1979;10:221–228.
- Thomas MG, Quiroz AC, Rice JC, Sander GE, Giles TD. Anti-anginal effects of clonidine.J Cardiovasc Pharmacol 1986;8(Suppl 3):S69-S75.
- Simoons ML, Tummers J, van Meurs-van Woezik H, van Domurg R. Alinidine, a new agent which lowers heart rate in patients with angina pectoris.Eur Heart J 1982;3:542–545.
- Schurmans J, Piessens J, Kesteloot H, De Geest H. Comparative effects of alinidine and propranolol in ischaemic heart disease.Eur J Clin Pharmacol 1982;23:389–396.
- Meinertz T, Kasper W, Meier R, et al. Alinidine in angina.Clin Pharmacol Ther 1983;34:770–776.
- Mohrman DE, Feigl EO. Competition between sympathetic vasoconstriction and metabolic vasodilation in the canine coronary circulation.Circ Res 1978;42:79–86.
- Heusch G, Deussen A. The effects of cardiac sympathetic nerve stimulation on perfusion of stenotic coronary arteries in the dog.Circ Res 1983;53:8–15.
- Seitelberger R, Guth BD, Heusch G, Lee JD, Katayama K, Ross J Jr. Intracoronary α2-adrenergic receptor blockade attenuates ischaemia in conscious dogs during exercise.Circ Res 1988;62:536–542.
- Kitakaze M, Hori M, Gotoh K, et al. Beneficial effects of α2-adrenoceptor activity on ischaemic myocardium during coronary hypoperfusion in dogs.Circ Res 1989;65:1632–1645.
- Exercise tolerance in angina is improved by mivazerol—An alpha2-adrenoceptor agonist
Cardiovascular Drugs and Therapy
Volume 7, Issue 6 , pp 929-934
- Cover Date
- Print ISSN
- Online ISSN
- Kluwer Academic Publishers
- Additional Links
- alpha2 adrenoceptor
- exercise tolerance
- Industry Sectors